LP™ Optical Cell Barcoding Platform
Research Tool for Single-Cell Analysis
DevelopmentActive
Key Facts
About LASE Innovation
LASE Innovation is an early-stage, private company based in Cambridge, MA, founded in 2019. It has developed a patented laser particle (LP™) technology for optical cell barcoding, allowing researchers to track hundreds of thousands to millions of individual cells over time and across different experimental modalities. The company operates primarily as a platform tools provider, with its first commercial service launched in collaboration with Talon Biomarkers in 2025. It has secured non-dilutive funding through SBIR grants from the National Cancer Institute (NCI) and is focused on enabling next-generation single-cell analysis for drug discovery and biomarker development.
View full company profileTherapeutic Areas
Other Research Tool for Single-Cell Analysis Drugs
| Drug | Company | Phase |
|---|---|---|
| HIVE CLX Solution | Honeycomb Biotechnologies | Pre-commercial |